Close

Medtronic acquires Influent Medical’s Repose product line

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...
Medtronic, Inc.announced the acquisition of InfluENT Medical’s Repose GAHM product line for the treatment of obstructive sleep apnea (OSA). The acquisition expands Medtronic’s Surgical Technologies business unit portfolio of treatments for sleep-disordered breathing.

Medtronic, Inc.announced the acquisition of InfluENT Medical’s Repose GAHM product line for the treatment of obstructive sleep apnea (OSA). The acquisition expands Medtronic’s Surgical Technologies business unit portfolio of treatments for sleep-disordered breathing.

The Repose Genioglossus Advancement and Hyoid Advancement (GAHA) surgical devices advance the base of the tongue and the hyoid bone to prevent obstructions of the airway during sleep. In addition to the Repose System, the Surgical Technologies business of Medtronic offers the Pillar® Palatal Implant System, used to treat the soft palate component of sleep breathing disorders, and an existing family of market-leading ENT instruments used to treat other upper airway obstructions.

Bob Blankemeyer, president of the Surgical Technologies business and senior vice president at Medtronic said, he Repose GAHM devices provide our surgeon customers with another minimally invasive, low morbidity option to treat patients suffering from OSA.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back